Poll: At $14,105 per Year, Is Dolutegravir Fairly Priced?

The price of the recently approved once-daily integrase inhibitor dolutegravir — around $14k/year — has generated some controversy. HIV treatment is expensive, says Dr. Paul Sax, but is the additional cost of one drug over another justified? Read two opposite perspectives on dolutegravir pricing and then take the HIV and ID Observations blog poll.